Published in Infect Immun on January 29, 2009
Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog (2011) 1.68
Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PLoS One (2013) 1.35
Role of the inflammasome, IL-1β, and IL-18 in bacterial infections. ScientificWorldJournal (2011) 1.15
Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol (2010) 1.14
Development of Burkholderia mallei and pseudomallei vaccines. Front Cell Infect Microbiol (2013) 1.08
Adenosine-5'-triphosphate (ATP) protects mice against bacterial infection by activation of the NLRP3 inflammasome. PLoS One (2013) 0.97
Toll-like receptor signaling in airborne Burkholderia thailandensis infection. Infect Immun (2009) 0.96
Evaluation of surrogate animal models of melioidosis. Front Microbiol (2010) 0.95
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep (2013) 0.91
Caspase-1-dependent and -independent cell death pathways in Burkholderia pseudomallei infection of macrophages. PLoS Pathog (2014) 0.91
Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages. PLoS Negl Trop Dis (2014) 0.89
Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis (2013) 0.84
BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei. Infect Immun (2014) 0.83
NLRC4 and TLR5 each contribute to host defense in respiratory melioidosis. PLoS Negl Trop Dis (2014) 0.80
Reassessing the Evolutionary Importance of Inflammasomes. J Immunol (2016) 0.80
Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis. PLoS Negl Trop Dis (2016) 0.79
The role of NOD2 in murine and human melioidosis. J Immunol (2013) 0.79
Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells. Virol J (2013) 0.77
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev (2017) 0.75
Interaction of Interferon gamma-induced reactive oxygen species with ceftazidime leads to synergistic killing of intracellular Burkholderia pseudomallei. Antimicrob Agents Chemother (2014) 0.75
Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines. PLoS One (2017) 0.75
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Melioidosis. Lancet (2003) 11.74
Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science (1995) 11.38
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol (2007) 6.36
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun (2005) 6.31
Melioidosis: review and update. Rev Infect Dis (1989) 6.22
Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J Biol Chem (2006) 5.11
Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med (2005) 5.00
The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol (2006) 4.70
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol (2002) 3.23
The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop (2000) 3.16
Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity (2000) 2.81
Melioidosis. Curr Opin Infect Dis (2002) 2.80
Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun (2000) 2.70
Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun (1999) 2.41
Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect Immun (2006) 2.35
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1996) 2.11
Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun (2002) 1.99
The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J Immunol (2007) 1.89
Caspase-1 inflammasomes in infection and inflammation. J Leukoc Biol (2007) 1.87
Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun (2007) 1.85
Roles of caspase-1 in Listeria infection in mice. Int Immunol (2004) 1.78
BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog (1998) 1.76
Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun (1999) 1.75
A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J Infect Dis (2006) 1.68
Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Cell Microbiol (2005) 1.62
Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis (2005) 1.56
Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun (2006) 1.45
Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Infect Immun (2008) 1.44
Intracytosolic Listeria monocytogenes induces cell death through caspase-1 activation in murine macrophages. Cell Microbiol (2007) 1.40
Salmonella-induced macrophage death: multiple mechanisms, different outcomes. Cell Microbiol (2004) 1.35
MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One (2008) 1.33
Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol (2003) 1.31
A novel role for neutrophils as critical activators of NK cells. J Immunol (2008) 1.22
Birc1e/Naip5 rapidly antagonizes modulation of phagosome maturation by Legionella pneumophila. Cell Microbiol (2006) 1.17
Dependency of caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm. J Immunol (2008) 1.09
Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun (2007) 1.07
Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J Immunol Methods (2009) 0.93
Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2). FEMS Immunol Med Microbiol (2008) 0.89
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res (2004) 3.94
Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15
Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J (2003) 2.87
Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun (2006) 2.24
Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis (2008) 2.24
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol (2003) 2.17
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun (2002) 1.99
Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum-sensing system. Cell Microbiol (2003) 1.75
Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl Trop Dis (2013) 1.72
Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Cell Microbiol (2005) 1.62
Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis (2012) 1.48
Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun (2006) 1.45
Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J Bacteriol (2004) 1.43
The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis. PLoS Pathog (2008) 1.43
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Res (2005) 1.35
Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med Microbiol (2008) 1.35
Global regulation of quorum sensing and virulence by VqsR in Pseudomonas aeruginosa. Microbiology (2004) 1.32
Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol (2003) 1.31
The BpsIR quorum-sensing system of Burkholderia pseudomallei. J Bacteriol (2005) 1.27
Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol (2010) 1.22
Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis (2006) 1.21
Melioidosis diagnostic workshop, 2013. Emerg Infect Dis (2015) 1.16
Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM. J Immunol (2010) 1.14
Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens. J Clin Microbiol (2007) 1.14
Identification of tomato plant as a novel host model for Burkholderia pseudomallei. BMC Microbiol (2010) 1.12
Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. Trans R Soc Trop Med Hyg (2008) 1.11
Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J Infect Dis (2008) 1.11
Electrospinning preparation, characterization and photocatalytic properties of Bi2O3 nanofibers. J Colloid Interface Sci (2009) 1.08
Regulation of type VI secretion system during Burkholderia pseudomallei infection. Infect Immun (2011) 1.07
Inter- and intraclonal diversity of the Pseudomonas aeruginosa proteome manifests within the secretome. J Bacteriol (2003) 1.07
Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest (2012) 1.06
Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. J Antimicrob Chemother (2008) 1.06
Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J Biol Chem (2006) 1.06
High photocatalytic activity of ZnO-carbon nanofiber heteroarchitectures. ACS Appl Mater Interfaces (2011) 1.05
Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei. Trends Microbiol (2010) 1.04
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT. J Nucl Med (2014) 1.02
A facile in situ hydrothermal method to SrTiO3/TiO2 nanofiber heterostructures with high photocatalytic activity. Langmuir (2011) 1.02
Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei. Mol Microbiol (2010) 1.02
The identification of surface proteins of Burkholderia pseudomallei. Vaccine (2006) 1.02
Highly sensitive direct detection and quantification of Burkholderia pseudomallei bacteria in environmental soil samples by using real-time PCR. Appl Environ Microbiol (2011) 1.02
Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Clin Vaccine Immunol (2009) 1.01
Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation. Blood (2007) 0.97
Diarrhea associated with afatinib: an oral ErbB family blocker. Expert Rev Anticancer Ther (2013) 0.96
Controllable assembly of aligned ZnO nanowires/belts arrays. J Phys Chem B (2005) 0.96
Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells. Am J Pathol (2004) 0.96
In situ assembly of well-dispersed Ag nanoparticles (AgNPs) on electrospun carbon nanofibers (CNFs) for catalytic reduction of 4-nitrophenol. Nanoscale (2011) 0.94
Improved culture-based detection and quantification of Burkholderia pseudomallei from soil. Trans R Soc Trop Med Hyg (2011) 0.94
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center. Eur J Cancer (2013) 0.93
Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J Immunol Methods (2009) 0.93
Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei. Front Microbiol (2012) 0.92
The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. BMC Immunol (2006) 0.91
NADPH-oxidase but not inducible nitric oxide synthase contributes to resistance in a murine Staphylococcus aureus Newman pneumonia model. Microbes Infect (2011) 0.90
Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments. Antimicrob Agents Chemother (2005) 0.90
Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol (2011) 0.90
Molecular epidemiology of Orientia tsutsugamushi in Cambodia and Central Vietnam reveals a broad region-wide genetic diversity. Infect Genet Evol (2011) 0.90
Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis. Infect Immun (2008) 0.89
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology. Eur J Nucl Med Mol Imaging (2014) 0.88
Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro. Infect Immun (2010) 0.88
Growth of ZnO nanostructures with different morphologies by using hydrothermal technique. J Phys Chem B (2006) 0.87
Circular dichroism in the photoelectron angular distributions of camphor and fenchone from multiphoton ionization with femtosecond laser pulses. Angew Chem Int Ed Engl (2012) 0.87
Gas dielectric transistor of CuPc single crystalline nanowire for SO₂ detection down to sub-ppm levels at room temperature. Adv Mater (2013) 0.86
Risk of stroke for carotid endarterectomy patients with contralateral carotid occlusion. Ann Vasc Surg (2008) 0.86
Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor. Proc Natl Acad Sci U S A (2013) 0.86
Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol (2002) 0.86
Association of melioidosis incidence with rainfall and humidity, Singapore, 2003-2012. Emerg Infect Dis (2015) 0.85
Inhibition of cullin RING ligases by cycle inhibiting factor: evidence for interference with Nedd8-induced conformational control. J Mol Biol (2011) 0.85
Electrospun nanofibers of V-doped TiO2 with high photocatalytic activity. J Colloid Interface Sci (2010) 0.85
Hierarchical assembly of ultrathin hexagonal SnS2 nanosheets onto electrospun TiO2 nanofibers: enhanced photocatalytic activity based on photoinduced interfacial charge transfer. Nanoscale (2012) 0.85
Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection. PLoS One (2009) 0.84
Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling. J Leukoc Biol (2003) 0.84
Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis (2013) 0.84
Electrospun nanofibers of p-type NiO/n-type ZnO heterojunctions with enhanced photocatalytic activity. ACS Appl Mater Interfaces (2010) 0.84
Influence of iNOS and COX on peroxiredoxin gene expression in primary macrophages. Free Radic Biol Med (2010) 0.83
BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei. Infect Immun (2014) 0.83
Heterostructured ZnO/Au nanoparticles-based resonant Raman scattering for protein detection. J Phys Chem B (2009) 0.83
SnO2 nanostructures-TiO2 nanofibers heterostructures: controlled fabrication and high photocatalytic properties. Inorg Chem (2009) 0.83
Carbon-modified BiVO4 microtubes embedded with Ag nanoparticles have high photocatalytic activity under visible light. Nanoscale (2012) 0.83
In situ assembly of well-dispersed gold nanoparticles on electrospun silica nanotubes for catalytic reduction of 4-nitrophenol. Chem Commun (Camb) (2011) 0.83
TiO(2)@carbon core/shell nanofibers: controllable preparation and enhanced visible photocatalytic properties. Nanoscale (2011) 0.83
Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun (2008) 0.82
Growth of dumbbell-like ZnO microcrystals under mild conditions and their photoluminescence properties. Inorg Chem (2007) 0.81